We are delighted to invite you to our ITX pharma virtual round table "Unlocking Opportunities: Indirect Tax Implications of Rebates, Market Access Strategies and ESG in the Health Industry".
Join us on Thursday, 20 February 2025, from 15:00 to 16:00 CET as we will keep our conversation going on the latest developments, innovations, and challenges in indirect tax, which are set to influence the pharma, healthcare, and life sciences industries.
During the session, our expert speakers from various territories will cover various key topics, offering practical insights and perspectives from their countries:
Mandatory and voluntary rebates in selected countries
Discover the latest developments relating to rebates within the pharma industry across different countries. We will discuss both mandatory and voluntary rebate schemes, providing critical insights into their impact on your VAT position.
Market Access and what to consider
Gain a deeper understanding of market access strategies and the essential factors to consider in the health industry. This discussion will cover regulatory landscapes and other vital indirect tax aspects.
ESG – an indirect tax topic along the supply chain?
Explore the intersection of Environmental, Social, and Governance (ESG) criteria and indirect taxation. We will address how ESG considerations are increasingly influencing supply chain decisions and the potential indirect tax implications for the health industry.
To register for this event, please click “Registration” in the menu above. Registration is open until three days before the event. We’ll send you an email with further information once you’ve registered.